Scientific Protein Labs
Generated 5/11/2026
Executive Summary
Scientific Protein Labs (SPL) is a privately held contract development and manufacturing organization (CDMO) based in Waunakee, Wisconsin, with over 45 years of experience in biologics and drug delivery. SPL specializes in the extraction, isolation, and purification of naturally derived materials, as well as fermentation, isolation, and recovery of therapeutic proteins. The company offers a broad spectrum of development and manufacturing services to support biopharmaceutical clients from early-stage through commercial production. Leveraging its expertise in natural product processing and protein therapeutics, SPL serves as a strategic partner for companies seeking reliable, high-quality outsourcing solutions. Although the company operates in a competitive CDMO landscape, its long-standing presence and specialized capabilities position it well for steady demand from the biologics and drug delivery sectors. With no disclosed pipeline products or recent news, SPL’s growth is likely driven by client engagements and facility expansions rather than company-specific clinical catalysts.
Upcoming Catalysts (preview)
- Q3 2026Announcement of major manufacturing partnership or capacity expansion40% success
- Q1 2027Certification or regulatory approval for new manufacturing capabilities30% success
- TBDPublic disclosure of financial performance or strategic investment20% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)